| IPMN | Intraductal papillary mucinous neoplasm |
| CT | Computed tomography |
| MRI | Magnetic resonance imaging |
| MRCP | Magnetic resonance cholangiopancreatography |
| PDAC | Pancreatic ductal adenocarcinoma |
| ICG | International consensus guidelines |
| MD-IPMN | Main duct IPMN |
| BD-IPMN | Branch duct IPMN |
| MPD | Main pancreatic duct |
| AGA | American Gastroenterological Association |
| EUS | Endoscopic ultrasound |
| FNA | Fine needle aspiration |
| HGD | High-grade dysplasia |
| CEA | Carcinoembryonic antigen |
| SCA | Serous cystadenoma |
| SPN | Solid pseudo-papillary neoplasm |
| MCN | Mucinous cystic neoplasm |
| GNAS | Guanine nucleotide binding protein, alpha-stimulating |
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
| NGAL | neutrophil gelatinase-associated lipocalin |
| MUC | Mucin |
| IL | Interleukin |
| PGE2 | Prostaglandin E2 |
| ELISA | Enzyme-linked immunosorbent assay |
| NSAID | Nonsteroidal anti-inflammatory drug |
| LGD | Low-grade dysplasia |
| miRNA | MicroRNA |
| NGS | Next Generation Sequencing |
| mAb | Monoclonal antibody |
| CEP | Colon epithelial protein |
| PCR | Polymerase chain reaction |
| LOH | Loss of heterozygosity |
| MOCA | Multivariate organization of combinatorial alterations |
| IMP | Integrated molecular pathology |
| PANCAN | Pancreatic Cancer Action Network |
| NCI | National Cancer Institute |